Artigo Revisado por pares

Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer

2018; Adis, Springer Healthcare; Volume: 58; Issue: 3 Linguagem: Inglês

10.1007/s40262-018-0701-2

ISSN

1179-1926

Autores

Carlos Fernández‐Teruel, Ignacio Ferreira González, Iñaki F. Trocóniz, Rubin Lubomirov, A. Soto, Salvador Fudio,

Tópico(s)

Lung Cancer Research Studies

Referência(s)